Belgian biopharmaceutical company UCB has agreed to invest approximately £1bn ($1.27bn) over the next five years to back the research and development of new medical treatments in the UK.
The commitment by UCB includes the construction of a new £150-200m research and development facility in or close to the wider Slough area.The new centre will house early manufacturing and commercial operations, and is expected to create about 650 jobs.UCB expects that the move will help in research t...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
